Skip to main content
. 2021 Jun 15;13(6):6568–6575.

Table 4.

The expressions of YAP1, E-cadherin, and vimentin in the two groups

Group Number of cases YAP1 E-cadherin vimentin
Nasal-polyps group 58 1.208±0.271 0.875±0.115 0.902±0.284
Control group 30 0.984±0.197 1.462±0.317 0.364±0.093
t - 4.008 12.639 10.076
P - 0.000 0.000 0.000